2011
DOI: 10.1016/j.brs.2010.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Infrared radiation has potential antidepressant and anxiolytic effects in animal model of depression and anxiety

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 30 publications
0
23
0
Order By: Relevance
“…In male rats, blue but not red light stimulation in the dark phase reduced immobility duration in the second FST session [216]. Exposure to infrared radiation may have potential antidepressant effects in the rat FST [217]. …”
Section: Test Design and Environmental Conditionsmentioning
confidence: 99%
“…In male rats, blue but not red light stimulation in the dark phase reduced immobility duration in the second FST session [216]. Exposure to infrared radiation may have potential antidepressant effects in the rat FST [217]. …”
Section: Test Design and Environmental Conditionsmentioning
confidence: 99%
“…Good outcomes and futile outcomes were defined as mRS scores ≤2 and 5-6, respectively. Rats tend to favor the closed arm when they feel strong anxiety (29).…”
Section: Reverse Transcription-quantitative Polymerase Chain Reactionmentioning
confidence: 99%
“…Low levels of light at these wavelengths modulates the release of nitric oxide (NO) (Uozumi et al, 2010) and increases both cerebral oxygenation (Wang et al, 2017) and blood flow (Salgado et al, 2015). Besides these effects, transcranial PBM can stimulate neurogenesis (Tanaka et al, 2011) and provide neuroprotection via antioxidant, anti-neuroinflammatory, and anti-apoptotic activities (De Taboada et al, 2011; Hamblin, 2017; Lu et al, 2017; Salehpour et al, 2017; Salehpour et al, 2018a). In particular, it has been demonstrated that transcranial PBM is able to increase regional cerebral blood flow in MDD patients (Schiffer et al, 2009).…”
Section: Introductionmentioning
confidence: 99%